Clinical Trial Update: Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating strategies to reduce risk of Plasmodium vivax after Plasmodium falciparum infections in co-endemic areas, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Malaria
• Vivax Malaria

Snippet

Sponsor: Menzies School of Health Research | Conditions: Malaria, Vivax Malaria | Phase 4 | Status: COMPLETED